Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
EBITDA Margin
83.27%
Quarterly · Period ending:
BIO EBITDA Margin
Latest reported83.27%period ending
Latest reported83.27%period ending
BIO Quarterly EBITDA Margin (100.00% → 83.27%)
Quarterly ebitda margin
High-resolution chart · PNG
BIO ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 18.7577% | |
| 25.1283% | |
| 14.0877% | |
| 14.9007% | |
| 15.8234% | |
| 21.6418% | |
| 11.9342% | |
| 11.2775% | |
| 15.6252% | |
| 17.4527% | |
| 12.2054% | |
| 7.5758% | |
| 11.0287% | |
| 15.6627% | |
| 9.9309% | |
| 8.0402% | |
| 11.2476% | |
| 14.0699% | |
| 12.8947% | |
| 13.6646% | |
| 13.9% | |
| 16.7128% | |
| 13.0677% | |
| 13.0248% | |
| 13.4831% | |
| 17.2625% | |
| 13.9607% | |
| 13.6038% | |
| 15.2761% | |
| 17.3913% | |
| 5.8419% | |
| 7.858% | |
| 8.6797% | |
| 10.559% | |
| 9.5346% | |
| 8.9059% | |
| 0% | |
| 15.6699% | |
| 9.1019% | |
| 10.9188% | |
| 9.9346% | |
| 14.2112% | |
| 13.5741% | |
| 9.7842% | |
| 11.0465% | |
| 13.8032% | |
| 10.3395% | |
| 10.5263% | |
| 13% | |
| 100% | |
| -236.0225% | |
| 100% | |
| 100% | |
| 100% | |
| -224.4898% | |
| 100% | |
| 100% | |
| 100% | |
| -237.3529% | |
| 100% | |
| 100% | |
| 100% | |
| -244.1176% | |
| 100% |